Weber Shandwick wins Lipitor account

Share this article:
Pfizer named Weber Shandwick PR agency of record for Lipitor following a break with WPP. Weber Shandwick was recently appointed agency of record for the firm's statin torcetrapib/atorvastatin.

The award, first reported in PRWeek, follows a review pitting Weber Shandwick, an Interpublic Group agency, against Omnicom's Fleishman-Hillard, WPP's GCI Group and independent APCO Worldwide.

In October, Pfizer parted ways with WPP network consortium WPP Health Success, which had handled the Lipitor, Norvasc and Caduet business globally for over two years. WPP Health Success did not pitch for the Lipitor business. WPP's Feinstein Kean continues to support Caduet in the US and Burson-Marsteller handles the brand globally.

The shift comes amid a series of frantic news cycles for the world's best-selling drug and its prospective follow-on. The American Heart Association, miffed that Pfizer released data ahead of its scheduled presentation at the group's conference, cancelled the slot altogether. More importantly, the data released showed that the new drug does elevate blood pressure, however minimally. Meanwhile, Pfizer won an appeals court ruling preserving Lipitor's patent exclusivity for three more years.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.